Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMF | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | SBK1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | XKR7 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | SYT1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | DOK6 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | UNK | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | DYM | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | CERS6 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | MARCKSL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |